Skin reactivity to thimerosal and phenol-preserved Montenegro antigen in Brazil

Acta Tropica

Volumn 101, Issue 1, 2007, Pages 25-30

  Fagundes, Aline ^a   Marzochi, Mauro C A ^a   Perez, Maurício ^b   Schubach, Armando ^a   Ferreira, Antonio ^c   Silva, Janaína P ^c   Schubach, Tânia ^a   Marzochi, Keyla B Feldman ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Leishmania; Phenol; Skin test; Thimerosal

Indexed keywords

ANTIGEN; LEISHMANIN; METHIONINE; PHENOL; PRESERVATIVE; REAGENT; SODIUM CHLORIDE; THIOMERSAL; UNCLASSIFIED DRUG;

ANTIGEN; LEISHMANIASIS; PHENOL; PRESERVATION;

ADULT; ARTICLE; BLISTER; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHEMA; FALSE POSITIVE RESULT; FEVER; HUMAN; HUMAN EXPERIMENT; LEISHMANIASIS; MALE; NORMAL HUMAN; PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN EDEMA; SKIN MANIFESTATION; SKIN PRURITUS; SKIN TEST; URTICARIA;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, PROTOZOAN; BRAZIL; DOUBLE-BLIND METHOD; HUMANS; LEISHMANIA; LEISHMANIASIS; MALE; PRESERVATIVES, PHARMACEUTICAL; SKIN TESTS; THIMEROSAL;

BRAZIL; SOUTH AMERICA;

EID: 33846794915     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.11.007     Document Type: Article

References (23)

1. Abramson M.A., Dietze R., Frucht D.M., Schwantz R., and Kenney R.T. Comparison of new and old world leishmanins in an endemic region of Brazil. Clin. Infect Dis. 20 (1995) 1292-1297
2. Akuffo H., Darce M., Maasho K., and Berhan T.Y. In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testing. Am. J. Trop. Med. Hyg. 53 (1995) 16-22
3. Alimohammadian M.H., Kivanjah M., Pak F., Gaznavia A., and Kharazmi A. Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients [see comments]. Trans. R. Soc. Trop. Med Hyg. 87 (1993) 550-551
4. Ben Salah A., Louzir H., Chlif S., Mokni M., Zaatour A., Raouene M., Ismail R.B., and Dellagi K. The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis. J. Infect. Dis. 192 (2005) 1981-1987
5. Cox N.H., and Forsyth A. Thiomersal allergy and vaccination reactions. Contact Dermatitis 18 (1988) 229-233
6. de Castro E.A., Luz E., Telles F.Q., Pandey A., Biseto A., Dinaiski M., Sbalqueiro I., and Soccol V.T. Eco-epidemiological survey of Leishmania (Viannia) braziliensis American cutaneous and mucocutaneous leishmaniasis in Ribeira Valley River, Parana State. Brazil. Acta Trop. 93 (2005) 141-149
7. De Luca P.M., Mayrink W., Santiago M.A., Nogueira R., Conceicao-Silva F., Melo G., and Mendonca S.C. Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 709-712
8. Forstrom L., Hannuksela M., Kousa M., and Lehmuskallio E. Merthiolate hypersensitivity and vaccination. Contact Dermatitis 6 (1980) 241-245
9. Goncalo M., Figueiredo A., and Goncalo S. Hypersensitivity to thimerosal: the sensitizing moiety. Contact Dermatitis 34 (1996) 201-203
10. Lebrec H., Bachot N., Gaspard I., Kerdine S., Guinnepain M.T., Laurent J., and Pallardy M. Mechanisms of drug-induced allergic contact dermatitis. Cell. Biol. Toxicol. 15 (1999) 57-62
11. Maibach H.I. False-positive intradermal skin tests and thimerosal. JAMA 220 (1972) 126
12. Marzochi K.B., Marzochi M.A., Silva A.F., Grativol N., Duarte R., Confort E.M., and Modabber F. Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil. Mem. Inst. Oswaldo Cruz. 93 (1998) 205-212
13. Melo M.N., Mayrink W., da Costa C.A., Magalhaes P.A., Dias M., Williams P., Araujo F.G., Coelho M.V., and Batista S.M. Standardization of the Montenegro antigen. Rev. Inst. Med. Trop. Sao Paulo 19 (1977) 161-164
14. Montenegro J. A cutis reacção na leishmaniose. Ann. Fac. Med. Univ. São Paulo 1 (1926) 323-330
15. Nascimento M.D., Alcantara-Neves N.M., Muniz M.E., Nunes S.F., Paranhos M., and de Carvalho L.C. Induction and modulation of the immune response to Leishmania by Montenegro's skin test. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 91-93
16. Osawa J., Kitamura K., Ikezawa Z., and Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Dermatitis 24 (1991) 178-182
17. Reed S.G., Badaro R., Masur H., Carvalho E.M., Lorenco R., Lisboa A., Teixeira R., Johnson Jr. W.D., and Jones T.C. Selection of a skin test antigen for American visceral leishmaniasis. Am. J. Trop. Med. Hyg. 35 (1986) 79-85
18. Restrepo Isaza M. The Montenegro test in the epidemiology of South American leishmaniasis. Bol. Oficina Sanit Panam 89 (1980) 130-138
19. Satti I., el Hassan A., Khalil el T.A., and Akuffo H. The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 565-567
20. Seidenari S., Manzini B.M., Modenese M., and Danese P. Contact sensitization to thimerosal in healthy subjects. G. Ital. Dermatol. Venereol. 124 (1989) 335-339
21. Sokal J.E. Editorial: measurement of delayed skin-test responses. N. Engl. J. Med. 293 (1975) 501-502
22. Souza W.J., Sabroza P.C., Santos C.S., de Sousa E., Henrique M.F., and Coutinho S.G. Montenegro skin tests for American cutaneous leishmaniasis carried out on school children in Rio de Janeiro Brazil: an indicator of transmission risk. Acta Trop. 52 (1992) 111-119
23. Zijlstra E.E., and el-Hassan A.M. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 425-427